Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Apr. 30, 2022
Apr. 30, 2021
Income Statement [Abstract]        
Revenue
Expenses:        
Research and development 7,030,607 7,589,779 20,501,917 26,304,520
General and administrative 2,517,105 2,847,151 8,377,722 8,198,580
Loss from operations (9,547,712) (10,436,930) (28,879,639) (34,503,100)
Gain on extinguishment of debt 960,790 960,790
Other income (expense), net 2,182 1,723 (2,412) 660
Interest expense (2,701) (1,732) (16,128) (12,587)
Foreign currency exchange gain (loss), net (36,191) 35,365 (399,338) 187,039
Loss before income taxes (9,584,422) (9,440,784) (29,297,517) (33,367,198)
Income tax (benefit) expense (3,337,117) 1,542 (3,334,167) 4,492
Net loss $ (6,247,305) $ (9,442,326) $ (25,963,350) $ (33,371,690)
Basic and diluted net loss per common share $ (0.16) $ (0.25) $ (0.66) $ (1.08)
Weighted average shares used in computing basic and diluted net loss per common share 39,355,672 37,335,563 39,281,841 30,857,405